Multi-Cell Models for Neuroinflammation and Myelination

Driving momentum and supporting success in neuroscience drug discovery.

Neuroscience drug discovery is complex and time-consuming. The vast majority of drug candidates fail before reaching clinical trials and for most neurodegenerative diseases, there are no disease-modifying therapies.

First Name

Last Name

Phone Number

Job Title

Company Name

Country

If you wish to opt out of data collection, marketing communications, or any other services provided by Charles River privacy policy, please complete and submit the form below.

@CharlesRiver

Multi-Cell Models for Neuroinflammation and Myelination

Subscribe To Our Newsletter